Home › Psychomotor Agitation › Massachusetts
Psychomotor Agitation clinical trials in Massachusetts
3 studies for Psychomotor Agitation are looking for participants at sites in Massachusetts.
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Boston Center for Memory, Newton
- Local Institution - 2615, Worcester
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
- Vitalix, Worcester
RecruitingPhase 2
All ages · All sexes · Updated Sep 16, 2026 · NCT06052254Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- K2 Medical Research, Foxborough
- Local Institution - 0051, South Dartmouth
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.